Invivyd (IVVD) Non Operating Income (2021 - 2025)
Invivyd (IVVD) posted Non Operating Income of $1.5 million for Q4 2025, up 168.54% on a QoQ basis from $553000.0 in Q3 2025, and up 88.93% year-over-year from $786000.0 in Q4 2024.
Invivyd (IVVD) Non Operating Income (2021 - 2025) Analysis & Trends
Invivyd's Non Operating Income history runs 5 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- Quarterly Non Operating Income rose 88.93% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 55.82% YoY) and the FY2025 annual result came in at $3.1 million, down 55.82% from the prior year.
- Non Operating Income was $1.5 million for Q4 2025 at Invivyd, up from $553000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3.8 million in Q1 2023 and bottomed at $9000.0 in Q1 2021.
- A 5-year average of $1.5 million and a median of $1.1 million in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 7479.17% — and 2025, when it sank 80.0%.
- Invivyd's Non Operating Income stood at $48000.0 in 2021, then surged by 7479.17% to $3.6 million in 2022, then retreated by 14.84% to $3.1 million in 2023, then sank by 74.63% to $786000.0 in 2024, then jumped by 88.93% to $1.5 million in 2025.
- Business Quant data shows IVVD's Non Operating Income at $1.5 million in Q4 2025, $553000.0 in Q3 2025, and $400000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Invivyd | 105.60 Mn | -121.09 Mn | 16.07 Mn | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 553,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 786,000.00 |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 3.64 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 759,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 43,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | 9,000.00 |